premargin

Element List	Explanation
Introduction	The Board of Directors of Jana Medical Company is pleased to announce to its valued shareholders the results of the Ordinary General Assembly meeting (the first meeting), which was held at 19:00 (7:00 PM) on Sunday, 29-07-1447 H, corresponding to 18-01-2026 G. The meeting was conducted both in-person and via modern technology (remotely) through the Tadawulaty platform, following the completion of the legal quorum required for the validity of the Ordinary General Assembly meeting.
City and Location of the General Assembly's Meeting	Riyadh - Head office – and through modern technology means using Tadawulaty Platform.
Date of the General Assembly's Meeting	2026-01-18 Corresponding to 1447-07-29
Time of the General Assembly’s Meeting	19:00
Percentage of Attending Shareholders	28.75
Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees	The following members of the Board of Directors attended the Ordinary General Assembly meeting: 1. Abdullah bin Abdulrahman Al-Saadan – Board Member and Chairman of the Assembly 2. Rassam bin Sultan Al-Otaibi – Board Member 3. Abdullah bin Ismail Al-Khatib – Board Member 4. Fahad bin Mishaal Muhayya – Board Member The following members of the Board of Directors were absent from the General Assembly meeting: 1. Eid bin Sultan Al-Otaibi – Chairman of the Board of Directors 2. Hani Kamal Khidr Najm – Vice-Chairman of the Board of Directors
Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf	Mr. Abdullah Al-Omari – Chairman of the Audit Committee – also apologized for being unable to attend the meeting
Voting Results on the Items of the General Assembly's Meeting Agenda's	1) Approval of the appointment of M/S Sultan Ahmed Al-Shubaily (Certified Public Accountants & Auditors) as the Company’s external auditor from among the candidates based on the Audit Committee's recommendation. The auditor will examine, review, and audit the annual and semi-annual financial statements for the fiscal year 2025, for a total fee of SAR (300,000) excluding Value Added Tax (VAT). 2) Disapproval of the Board of Directors' decision to appoint Mr. Ziad bin Saleh Al-Sulais as an Executive Board Member, effective from his appointment date on 22-11-2025, to complete the Board's term until the current cycle expires on 27-07-2026, succeeding the former member, Mr. Fahad Mishaal Al-Ali (Non-Executive Member).
Additional Information	Please note and be advised that the final result for the second item is "Non-approval". This is due to the majority of the votes represented in the General Assembly opting for "Abstention" rather than voting in favor or against.

Jana Medical Co. Announces the Results of the Ordinary General Assembly Meeting (First Meeting)